Amsterdam (dpa) – The first corona vaccine for children under twelve could soon be available in Europe.
The European Medicines Agency EMA wants to decide on the approval of the corona vaccine from the manufacturer Pfizer / Biontech for children from the age of five. The responsible experts have examined the data on the risks and effectiveness of the vaccine in five to eleven year olds for a good two months and now want to complete the assessment.
If the EMA experts give the green light, the EU Commission officially has to give its approval – but this is a matter of form. In Germany, according to Federal Health Minister Jens Spahn (CDU), 2.4 million doses of the Biontech / Pfizer vaccine would not be available for children until December 20.
In Europe, the vaccine from Pfizer and Biontech has so far only been approved for people aged twelve and over. But in Israel and also in the USA, children from the age of five can be vaccinated with it.
Stiko boss shows understanding and skepticism towards child vaccination
The chairman of the Standing Vaccination Commission (Stiko), Thomas Mertens, can understand in his own words if parents are skeptical about vaccinating their children. “I can understand that very well, and it basically corresponds to the problem that Stiko is facing with its recommendation – namely weighing up the benefits and possible” residual risks “for children in this age group,” says Mertens of the “Schwäbische Zeitung” ».
The Standing Vaccination Commission (Stiko) wants to make its recommendation on corona vaccination for children from five to eleven years before the end of the year. As an independent body, Stiko develops vaccination recommendations and looks at the benefits for individuals and the entire population.
© dpa-infocom, dpa: 211125-99-136237 / 3